What Causes MS?

• immunology (the study of the body’s immune system)
• epidemiology (the study of disease patterns in large groups of people)
• genetics (understanding the genes that may not be functioning correctly in people who develop MS)
• infectious agents (such as viruses)

In MS, an abnormal immune response causes inflammation and damage in the CNS. Many different cells are involved in the abnormal immune response. Two important types of immune cells are T cells and B cells. 

• T cells become activated in the lymph system and in MS, enter the CNS through blood vessels. Once in the CNS, T cells release chemicals that cause inflammation and damage. This results in damage to myelin, nerve fibers and the cells that make myelin. T cells are also important to help activate B cells and call on other immune system cells to participate in the immune attack.
• T regulatory cells, a type of T cell, dampen or turn off inflammation. In MS, T regulatory cells to not function correctly and do not effectively turn off inflammation.
• Cytotoxic or “killer” T cells directly attack and destroy cells bearing certain characteristics
• B cells  become activated with the help of T cells. B cells produce antibodies and stimulate other proteins and in MS, these cause damage in the CNS.

Researchers continue to search for other cells and processes that could be involved in MS. Ongoing efforts to learn more about the immune-mediated process in MS — what sets it in motion, and how to slow or stop it — will bring us closer to understanding the cause of MS, better therapies and ultimately a cure.

Although the cause of MS is not known, more is being learned about environmental factors that contribute to the risk of developing MS.  There is no single risk factor that provokes MS, but several factors are believed to contribute to the overall risk.

Geographic gradient
MS is known to occur more frequently in areas that are farther from the equator. Epidemiologists — scientists who study disease patterns in large groups of people— are looking at variations in geography, demographics (age, gender and ethnic background), genetics, infectious causes and migration patterns in an effort to understand why.

Studies have shown that people born in an area with a high risk of MS who then move — or migrate — to an area with a lower risk before the age of 15 assume the risk of their new area. Such data suggest that exposure to some environmental agent before puberty may predispose a person to develop MS later on.

MS “clusters” — the perception that very high numbers of cases of MS have occurred in a specific time period or location — may provide clues to environmental or genetic risk for the disease. So far, cluster studies in MS have not produced clear evidence for the existence of any causative or triggering factor or factors in MS.

Vitamin D
Growing evidence suggests that vitamin D plays an important role in MS. Low vitamin D levels in the blood have been identified as a risk factor for the development of MS.  Some researchers believe that sun exposure (the natural source of Vitamin D) may help to explain the north-south distribution of MS. People who live closer to the equator are exposed to greater amounts of sunlight year-round. As a result, they tend to have higher levels of naturally-produced vitamin D, which is thought to support immune function and may help protect against immune-mediated diseases like MS.

Smoking
The evidence is also growing that smoking plays an important role in MS. Studies have shown that smoking increases a person’s risk of developing MS and is associated with more severe disease and more rapid disease progression. Fortunately, the evidence also suggests that stopping smoking — whether before or after the onset of MS — is associated with a slower progression of disability.

Obesity
Several studies have shown that obesity in childhood and adolescence, particularly in girls, increased the risk of later developing MS. Other studies have shown that obesity in early adulthood may also contribute to an increased risk of developing MS.  Also, obesity may contribute to inflammation and more MS activity in those already diagnosed with MS.

Many viruses and bacteria — including measles, canine distemper, human herpes virus-6, Epstein-Barr virus (EBV), and Chlamydia pneumonia — have been or are being investigated to determine if they are involved in the development of MS.  EBV, the virus that causes mononucleosis, has received significant attention in recent years. A growing number of research findings indicate that previous infection with EBV contributes to the risk of developing MS.

MS is not an inherited disease, meaning it is not a disease that is passed down from generation to generation.  However, in MS there is genetic risk that may be inherited. In the general population, the risk of developing MS is about 1 in 750 - 1000. In identical twins, if one twin has MS the risk that the other twin will develop MS is about 1 in 4. The risk of developing MS is also increased when other first degree relative (parents, siblings and children) have MS, but far less than in identical twins.

About 200 genes have been identified that each contribute a small amount to the overall risk of developing MS. Research is ongoing to better understand genetic risk and other factors that contribute to the development of MS.
 

• Environmental allergies
• Exposure to household pets
• Exposure to the heavy metals - mercury (including mercury amalgam tooth fillings), lead or manganese.
• Organic (chemical) solvents